Implications of potential cure in acute myelogenous leukemia: Development of subsequent cancer and return to work

Blood

Volumn 90, Issue 12, 1997, Pages 4719-4724

  De Lima, Marcos ^a   Strom, Sara S ^a   Keating, Michael ^a   Kantarjian, Hagop ^a   Pierce, Sherry ^a   O'Brien, Susan ^a   Freireich, Emil ^a   Estey, Elihu ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0031467498     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4719     Document Type: Article

References (19)

1. Preisler HD, Anderson K, Rai K, Cuttner J, Yates J, DuPre E, Holland JF: The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: A study of 760 patients with a minimal follow-up time of 6 years. Br J Haematol 71:189, 1989
2. Bennett JM, Andersen JW, Cassileth PA: Long term survival in acute myeloid leukemia: The Eastern Cooperative Oncology Group (ECOG) experience. Leuk Res 15:223, 1991
3. Keating MJ, McCredie KB, Bodey GP, Smith TL, Gehan E, Freireich EJ: Improved prospects for long-term survival in adults with acute myelogenous leukemia. JAMA 248:2481, 1982
4. Bandini G, Zuffa E, Rosti G, Battista R, D'Emilio E, Leoni F, Ciolli S, Barbui T, Bassan R, Todeschini G, Perona G, Scapoli G, Mangoni L, Morra E, DiPrisco U, Visani G, Tura S: Long-term outcome of adults with acute myelogenous leukaemia: Results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years. Br J Haematol 77:486, 1991
5. Whittaker JA, Reizenstein P, Callender ST, Cornwall GG, Delamore IW, Gale RP, Gobbi M, Jacobs P, Lantz B, Maiolo AT, Rees JK, Van Slyck EJ, Van HV: Long survival in acute myelogenous leukaemia: An international collaborative study. BMJ 282:692, 1981
6. Passe S, Mike V, Mertelsmann R, Gee TS, Clarkson BD: Acute nonlymphoblastic leukemia: Prognostic factors in adults with long-term follow-up. Cancer 50:1462, 1982
7. Keating MJ, Kantarjian H, Smith TL, Estey E, Walters R, Andersson B, Beran M, McCredie KB, Freireich EJ: Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 7:1071, 1989
8. Canellos GP, DeVita VT Jr, Arsenau JC: Second malignancies complicating Hodgkin's disease in remission. Lancet 1:947, 1975
9. van Leeuwen FE, Chorus AMJ, van den Belt-Dusebout AW, Hagenbeek A, Noyon R, van Kerkhoff EH, Pinedo HM, Somers R: Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063, 1994
10. Curtis RE, Boice JD, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN: Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 326:1745, 1992
11. Tallman MS, Gray R, Bennet JM: Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: Eastern Co-operative Oncology Group experience. J Clin Oncol 13:1557, 1995
12. Kaldor JM, Day NE, Pettersson F, Clarke EA, Pedersen D, Mehnert W, Bell J, Host H, Prior P, Karjalainen S, Neal F, Koch M, Band P, Choi W, Kim VP, Arslan A, Zaren B, Belch AR, Strom H, Kittelmann B, Fraser P, Stovall M: Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322:1, 1990
13. Simes RJ, Zelen M: Exploratory data analysis and the use of the hazard function for interpreting survival data: An investigator's primer. J Clin Oncol 3: 1418, 1985
14. Lustbader ED, McLaughlin L: CAGE: Cohort Analysis for Genetic Epidemiology. Philadelphia, PA, Fox Chase Cancer Center, 1995
15. Kuijten RR, Strom SS, Rorke LB, Boesel CP, Buckley JD, Meadows AT, Bunin GR: Family history of cancer and seizures in young children with brain tumors: A report from the Childrens Cancer Group (United States and Canada). Cancer Causes Control 4:455, 1993
16. Strong LC, Stine M, Lorsted TL: Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst 79:1213, 1987
17. de Nully Brown P, Hoffmann T, Hansen OP, Boesen AM, Grønbaek K, Hippe E, Jensen MK, Thorling K, Storm HH, Pedersen-Bjergaard J: Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Leukemia 11:37, 1997
18. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784, 1989
19. Lowsky R, Lipton J, Fyles G, Minden M, Meharchand J, Tejpar I, Atkins H, Sutcliffe S, Messner H: Secondary malignancies after bone marrow transplantation in adults. J Clin Oncol 12:2187, 1994